ribavirin has been researched along with Cryoglobulinemia in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (7.48) | 18.2507 |
| 2000's | 52 (48.60) | 29.6817 |
| 2010's | 45 (42.06) | 24.3611 |
| 2020's | 2 (1.87) | 2.80 |
| Authors | Studies |
|---|---|
| Doretto, P; Ermacora, A; Fumagalli, S; Gattei, V; Mauro, E; Mazzaro, C; Toffolutti, F; Tonizzo, M | 1 |
| Gattei, V; Mazzaro, C; Pozzato, G | 1 |
| Chowdhury, R; Tsen, A | 1 |
| Angiola, A; Caruso, A; Casari, S; Castelli, F; Festa, E; Gargiulo, F; Lanza, P; Nasta, P; Odolini, S; Rodella, A; Urbinati, L; Vavassori, A; Viganò, M; Zaltron, S | 1 |
| Casari, S; Castelli, F; Cattaneo, C; Chirico, C; Festa, E; Grecchi, C; Izzo, I; Odolini, S; Spinetti, A; Zaltron, S; Zanotti, P | 1 |
| Boglione, L; Cariti, G; Cusato, J; D'Avolio, A; De Nicolò, A; Di Perri, G; Pinna, SM | 1 |
| Abravanel, F; Alric, L; Del Bello, A; Esposito, L; Faguer, S; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Puissant-Lubrano, B | 1 |
| Banfi, G; Battista Fogazzi, G; Cresseri, D; Fabrizi, F; Francesca Donato, M; Martin, P; Messa, P | 1 |
| Cacoub, P; Saadoun, D; Terrier, B | 1 |
| Dixit, V; Fabrizi, F; Messa, P | 1 |
| Bazin-Karra, D; Blanc, F; Cacoub, P; Cazorla, C; Decaux, O; Karras, A; Lambotte, O; Longuet, M; Musset, L; Pialoux, G; Pol, S; Resche Rigon, M; Saadoun, D; Thibault, V; Vittecoq, D; Ziza, JM | 1 |
| Du, YJ; Li, X; Lu, RH; Wu, H; Xu, Y; Yu, JY; Zhang, L; Zou, HB | 1 |
| Gordovskaia, NB; Ignatova, TM; Korotchaeva, IuV; Kozlovskaia, LV; Milovanova, SIu | 1 |
| Chernova, O; Ignatova, T; Moiseev, S; Novikov, P | 1 |
| Boldrini, B; Caini, P; Fabbrizzi, A; Fognani, E; Gragnani, L; Laffi, G; Monti, M; Piluso, A; Ranieri, J; Triboli, E; Urraro, T; Zignego, AL | 1 |
| Cacoub, P; Saadoun, D | 2 |
| Cornella, S; Shah, NL; Stine, JG | 1 |
| Bazin-Kara, D; Blanc, F; Cacoub, P; Cazorla, C; Decaux, O; Karras, A; Lambotte, O; Musset, L; Peltier, J; Pialoux, G; Pol, S; Resche Rigon, M; Saadoun, D; Thibault, V; Vittecoq, D; Ziza, JM | 1 |
| Arena, U; Boldrini, B; Fabbrizzi, A; Fognani, E; Gragnani, L; Iannacone, C; Laffi, G; Monti, M; Piluso, A; Ranieri, J; Stasi, C; Urraro, T; Zignego, AL | 1 |
| Benstead, TJ; Chalk, CH; Parks, NE | 1 |
| Gattei, V; Mauro, E; Mazzaro, C | 1 |
| Del Bello, A; Guilbeau-Frugier, C; Izopet, J; Josse, AG; Kamar, N; Rostaing, L | 1 |
| Qadir, A | 1 |
| Allegra, S; Boglione, L; Cariti, G; Cusato, J; D'Avolio, A; Di Perri, G | 1 |
| Calabrese, LH; Vassilopoulos, D | 1 |
| Craxì, A; Feld, JJ; Forton, D; Manns, MP; Negro, F; Sulkowski, MS | 1 |
| Bloom, AK; Chung, RT; Gustafson, JL; Hashemi, N; Kim, AY; Lin, MV; Lundquist, AL; Sise, ME; Steele, D; Thadhani, R; Thiim, M; Williams, WW; Wisocky, J | 1 |
| Alric, L; Cacoub, P; Costopoulos, M; Fontaine, H; Guillaud, C; Hezode, C; Izzedine, H; Le Garff-Tavernier, M; Mallet, M; Musset, L; Plaisier, A; Pol, S; Poynard, T; Saadoun, D; Si Ahmed, SN; Thibault, V | 1 |
| Flemming, JA; Lowe, CE | 1 |
| Casato, M; Ceccotti, G; Colantuono, S; De Santis, A; Del Padre, M; Fiorilli, M; Fognani, E; Gianni, E; Gragnani, L; Mitrevski, M; Monti, M; Perez, M; Petraccia, L; Pulsoni, A; Stasi, C; Urraro, T; Visentini, M; Zignego, AL | 1 |
| Moiseev, S; Mukhin, N; Novikov, P | 1 |
| Brito-Zerón, P; Cacoub, P; Casato, M; Ferri, C; Lamprecht, P; Mangia, A; Ramos-Casals, M; Retamozo, S; Saadoun, D; Tzioufas, AG; Younossi, ZM; Zignego, AL | 1 |
| Alric, L; Bellier, B; Cacoub, P; Comarmond, C; Costopoulos, M; Desbois, AC; Fontaine, H; Garrido, M; Klatzmann, D; Le Garff-Tavernier, M; Maciejewski, A; Musset, L; Pol, S; Poynard, T; Rosenzwajg, M; Saadoun, D; Si Ahmed, SN | 1 |
| Almarzooqi, S; Emery, JS; Feld, JJ; Janssen, HLA; Kowgier, M; Kuczynski, M; La, D; Shah, H; Wong, D | 1 |
| Guillevin, L; Pagnoux, C | 1 |
| Cacoub, P; Klatzmann, D; Landau, DA; Rosenzwajg, M; Saadoun, D; Trébeden-Negre, H | 1 |
| Jabłońska, J; Kozłowska, J | 1 |
| Cacoub, P; Landau, DA; Resche-Rigon, M; Saadoun, D; Scerra, S; Sene, D | 1 |
| Chironna, M; Conteduca, V; Dammacco, F; De Re, V; Gatti, P; Lauletta, G; Mariggiò, MA; Russi, S; Sansonno, D; Sansonno, S; Tucci, FA | 1 |
| Blanc, F; Cacoub, P; Coppéré, B; Karras, A; Musset, L; Perard, L; Piette, JC; Resche Rigon, M; Rosenzwajg, M; Saadoun, D; Schoindre, Y; Sene, D; Terrier, B | 1 |
| Hirai, Y; Kadoya, H; Matsuda, J; Moriwaki, T; Namba, T; Shiba, R; Takeji, M; Yamada, Y; Yamamoto, T; Yamauchi, A; Yoshihara, H | 1 |
| Fais, V; Gonçales, ES; Gonçales, FL; Gonçales, NS; Macedo de Oliveira, A; Pavan, MH; Tozzo, R; Vigani, AG | 1 |
| Atzeni, F; Bonacci, E; Bruno, R; Bruno, S; Campanini, M; Candela, M; Castelnovo, L; De Vita, S; Ferri, C; Filippini, D; Gabrielli, A; Gaeta, GB; Galli, M; Marson, P; Mascia, MT; Mazzaro, C; Mazzotta, F; Meroni, P; Montecucco, C; Monti, G; Ossi, E; Piccinino, F; Pietrogrande, M; Pioltelli, P; Prati, D; Puoti, M; Quartuccio, L; Renoldi, P; Riboldi, P; Riva, A; Roccatello, D; Saccardo, F; Sagnelli, E; Sansonno, D; Sarzi-Puttini, P; Scaini, P; Scarpato, S; Sinico, R; Sollima, S; Taliani, G; Tavoni, A; Zignego, AL | 1 |
| Colucci, G; Grandaliano, G; Manno, C; Schena, FP | 1 |
| Risum, M | 1 |
| Masarone, M; Persico, M | 1 |
| Ermacora, A; Mauro, E; Mazzaro, C; Pedata, M | 1 |
| Fan, XH; Liu, LC; Lu, HY; Shan, Y; Wang, LF; Wei, L; Wu, CH; Xu, XY; Yao, Y | 1 |
| Fan, XH; Lu, HY; Wang, LF; Wei, L; Wu, CH; Xu, XY; Yao, Y; Zheng, YY | 1 |
| Ignatova, TM; Mukhin, NA | 1 |
| Cacoub, P | 1 |
| Duclos-Vallée, JC | 1 |
| Alain, S; Denis, F; Karaaslan, H; Le Meur, Y; Liozon, E; Loustaud-Ratti, V; Paraf, F; Vidal, E | 1 |
| Chung, RT; Cosimi, AB; Pascual, AM; Sikaneta, T; Williams, WW | 1 |
| Emens, LA; Sulkowski, MS | 1 |
| Jasin, HE; Medhekar, S; Nutt, A; Raufman, JP | 1 |
| Bandi, L | 1 |
| Abou Ayache, R; Bridoux, F; Goujon, JM; Provôt, F; Touchard, G | 1 |
| Baio, P; Bellavita, P; Bertani, T; Caldara, R; Luliri, P; Mazzucco, G; Misiani, R; Rossi, P; Tengattini, F | 1 |
| Baracetti, S; Bianchini, D; Comar, C; Donada, C; Donadon, V; Mazzaro, C; Nascimben, F; Pozzato, G; Zorat, F | 1 |
| Arlt, AC; Dennin, RH; Gause, A; Gross, WL; Gutzeit, O; Lamprecht, P; Lerin-Lozano, C; Merz, H; Peters, SO; Solbach, W; Voswinkel, J | 1 |
| Alric, L; Cacoub, P; Péron, JM; Piette, JC; Plaisier, E; Pourrat, J; Ronco, P; Rostaing, L; Thébault, S | 1 |
| Altman, RD; Concha, R; Herrera, I; Molina, EG; Schiff, ER | 1 |
| Matsumori, A | 1 |
| Chebli, JM; Gaburri, AK; Gaburri, PD; Martins Junior, EV | 1 |
| Cacoub, P; Lidove, O; Limal, N; Piette, JC; Saadoun, D; Sene, D | 1 |
| Caizzi, M; Carniello, G; Di Gennaro, G; Donada, C; Maso, LD; Mazzaro, C; Pozzato, G; Tirelli, U; Virgolini, L; Zorat, F | 1 |
| Calabrese, LH; Cooper, SM; Fessler, BJ; Gota, C; Levine, JW | 1 |
| Altuna, L; Castiella, A; Fernández, J | 1 |
| Gonçales, FL; Macedo-de-Oliveira, A; Pavan, MH; Pedro, MN; Vigani, AG | 1 |
| Bruchfeld, A; Lindahl, K; Schvarcz, R; Stahle, L | 1 |
| Cacciatore, P; Capani, F; Chincoli, C; Cosentino, L; D'Amico, E; di Pasqua, G; Palazzi, C; Pennese, E; Riario-Sforza, G | 1 |
| Alric, L; Kamar, N; Rostaing, L | 1 |
| Bryce, AH; Dispenzieri, A; Gertz, MA; Kyle, RA | 1 |
| Ahern, M; Cai, FZ; Smith, M | 1 |
| Bain, VG; Campbell, P; Zeman, M | 1 |
| Cacoub, P; Piette, JC; Resche-Rigon, M; Saadoun, D; Thibault, V | 1 |
| Colledan, M; Montalbano, M; Pasulo, L; Remuzzi, G; Sonzogni, A; Strazzabosco, M | 1 |
| Archimandritis, AJ; Hadziyannis, E; Karandreas, N; Kilidireas, C; Koskinas, J; Kountouras, D; Savvas, S | 1 |
| Fukumoto, K; Kanemasa, K; Sakai, K; Sumida, Y; Yoshida, N | 1 |
| Belair, ML; Jun, AS; Kedhar, SR; Sulkowski, M; Thorne, JE | 1 |
| Batista, RS; Gomes, AP; Massumoto, CM; Moura, LH; Rego, TC; Soares, LM | 1 |
| Brindani, F; Gemignani, F; Marbini, A | 1 |
| Allegri, L; Buzio, C; Garini, G; Lannuzzella, F; Vaglio, A | 1 |
| Baragiotta, AM; Biscontin, MG; Mazzaro, C; Pozzato, G; Spina, M; Tirelli, U; Zorat, F | 1 |
| Gatti, P; Lauletta, G; Montrone, M; Sansonno, D; Sansonno, L; Troiani, L; Tucci, FA | 1 |
| Cacoub, P; Karras, A; Perard, L; Resche-Rigon, M; Saadoun, D; Sene, D | 1 |
| Dammacco, F; Sansonno, D; Sansonno, L; Troiani, L; Tucci, FA | 1 |
| Cacoub, P; Fois, E; Halfon, P; Landau, DA; Marcellin, P; Martinot-Peignoux, M; Saadoun, D | 1 |
| Cacoub, P; Saadoun, D; Sène, D | 1 |
| Cacoub, P; Delluc, A; Piette, JC; Saadoun, D | 1 |
| Lopes, E; Lopes, LV; Silva, AE | 1 |
| Sharara, AI | 1 |
| Ashur, Y; Ilan, Y; Safadi, R; Shouval, D; Tur-Kaspa, R | 1 |
| Blanche, P; Bouscary, D | 1 |
| Bletry, O; Cacoub, P; Cosserat, J; Cretel, E; Durand, JM; Frances, C; Godeau, P; Kaplanski, G; Lunel-Fabiani, F; Soubeyrand, J | 1 |
| Alberti, A; Chemello, L; Crucitti, A; Donada, C; Donadon, V | 1 |
| Baio, P; Bellavita, P; Caldara, R; Ferruzzi, S; Misiani, R; Rossi, P; Tengattini, F | 1 |
| Albillos, A; Cacho, G; Calleja, JL; Domper, F; Escartín, P; Moreno-Otero, R; Rossi, I; Yebra, M | 1 |
| Faure, I; Leng, B; Lifermann, F; Mercié, P; Pellegrin, JL; Trimoulet, P; Viallard, JF; Vital, A | 1 |
| Cacoub, P; Lunel, F | 1 |
| Cervera, R; Font, J; García-Carrasco, M; Ramos-Casals, M; Trejo, O | 1 |
| Keren, D; Naschitz, JE; Rosner, I; Rozenbaum, M; Sabo, E; Slobodin, G; Toubi, E; Tsykounov, I; Yeshurun, D; Zuckerman, E | 1 |
| Allegri, L; Buzio, C; Carnevali, L; Catellani, W; Garini, G; Manganelli, P | 1 |
| Fontaine, H; Pol, S | 1 |
| Baldini, C; Bombardieri, S; Della Rossa, A; Tavoni, A | 1 |
29 review(s) available for ribavirin and Cryoglobulinemia
| Article | Year |
|---|---|
Hepatitis C virus-related cryoglobulinemic vasculitis.
Topics: Antiviral Agents; Blood Component Removal; Colchicine; Cryoglobulinemia; Female; Glucocorticoids; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; Rituximab; Vasculitis | 2021 |
Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
Topics: Antiviral Agents; Cryoglobulinemia; Hepacivirus; Hepatitis C; Humans; Interferons; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Ribavirin | 2021 |
Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Substitution; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Time Factors; Treatment Outcome | 2013 |
L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
Topics: Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; B-Lymphocytes; Blood Component Removal; Combined Modality Therapy; Cryoglobulinemia; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Plasmapheresis; Polyethylene Glycols; Protease Inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Rituximab | 2013 |
Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Models, Statistical; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2013 |
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Cyclophosphamide; Hepacivirus; Hepatitis C; Humans; Immunologic Factors; Interferon-alpha; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Ribavirin; Rituximab | 2014 |
HCV Treatments and Their Integration Into Rheumatology.
Topics: Antirheumatic Agents; Antiviral Agents; Arthritis; Cryoglobulinemia; Hepatitis C, Chronic; Humans; Interferon-alpha; Protease Inhibitors; Rheumatic Diseases; Ribavirin; Sialadenitis; Vasculitis | 2015 |
Extrahepatic morbidity and mortality of chronic hepatitis C.
Topics: Antiviral Agents; Cryoglobulinemia; Glomerulonephritis; Glucose Metabolism Disorders; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Lymphoma; Morbidity; Ribavirin; Vasculitis | 2015 |
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.
Topics: Antiviral Agents; Autoimmune Diseases; Cryoglobulinemia; Evidence-Based Medicine; Hepatitis C, Chronic; Humans; Interferons; Lymphoma, B-Cell; Ribavirin; Rituximab; Vasculitis | 2017 |
[Treatment of systemic vasculitides].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Azathioprine; Churg-Strauss Syndrome; Clinical Trials as Topic; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Granulomatosis with Polyangiitis; Hepatitis B; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Plasma Exchange; Polyarteritis Nodosa; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor; Recurrence; Ribavirin; Risk; Severity of Illness Index; Time Factors; Tumor Necrosis Factor-alpha; Vasculitis; Virus Diseases | 2008 |
[Difficulties in treatment of kidney diseases related to HCV infection].
Topics: Antiviral Agents; Cryoglobulinemia; Diet Therapy; Glomerulonephritis, Membranoproliferative; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Outcome | 2009 |
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.
Topics: Antibodies, Monoclonal, Murine-Derived; Blood Component Removal; Cryoglobulinemia; Drug Therapy, Combination; Evidence-Based Medicine; Expert Testimony; Glucocorticoids; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Practice Guidelines as Topic; Precision Medicine; Recombinant Proteins; Ribavirin; Rituximab; Virus Replication | 2011 |
Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cryoglobulinemia; Disease Progression; Drug Resistance, Viral; Female; Glomerulonephritis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Ribavirin; RNA, Viral; Sex Factors; Treatment Outcome; Viral Load | 2011 |
[Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Ribavirin; Rituximab; Vasculitis | 2012 |
[Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Topics: Antiviral Agents; Autoantibodies; Cryoglobulinemia; Drug Therapy, Combination; Fatigue; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Lymphoproliferative Disorders; Male; Middle Aged; Odds Ratio; Porphyria Cutanea Tarda; Pruritus; Ribavirin; Sjogren's Syndrome; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Vascular Diseases | 2002 |
[Treatment of hepatitis C virus associated extrahepatic manifestations].
Topics: Antiviral Agents; Autoantibodies; Clinical Enzyme Tests; Clinical Trials as Topic; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferons; Lichen Planus; Lymphoma, Non-Hodgkin; Porphyria Cutanea Tarda; Prospective Studies; Purpura, Thrombocytopenic; Retrospective Studies; Ribavirin; Sjogren's Syndrome; Thyroid Diseases; Time Factors; Transaminases | 2002 |
[Renal damage during type II cryoglobulinemia].
Topics: Acute Disease; Adrenal Cortex Hormones; Antiviral Agents; Biopsy; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney; Kidney Diseases; Male; Microscopy, Electron; Middle Aged; Nephritis; Nephrotic Syndrome; Plasma Exchange; Prognosis; Ribavirin | 2003 |
Relapsing polychondritis, chronic hepatitis C virus infection, and mixed cryoglobulemia.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferons; Leukemia, Myeloid, Acute; Polychondritis, Relapsing; Prednisone; Ribavirin | 2004 |
[Effect of IFN treatment for extrahepatic manifestations].
Topics: Antiviral Agents; Cardiomyopathies; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Middle Aged; Myositis; Ribavirin; Thyroid Diseases; Treatment Outcome | 2004 |
Hepatitis C virus infection, cryoglobulinemia, and peripheral neuropathy: a case report.
Topics: Antiviral Agents; Cryoglobulinemia; Electromyography; Hepacivirus; Hepatitis C; Humans; Immunoenzyme Techniques; Interferon-alpha; Male; Middle Aged; Polyneuropathies; Ribavirin | 2005 |
Treatment of hepatitis C-virus-related glomerulonephritis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Proteinuria; Renal Insufficiency; Renin-Angiotensin System; Ribavirin; Rituximab | 2006 |
Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; B-Lymphocytes; Cryoglobulinemia; Enzyme Inhibitors; Hepacivirus; Hepatitis C, Chronic; Humans; Immunoglobulin M; Interferons; Oligonucleotides, Antisense; Rheumatoid Factor; Ribavirin; Rituximab; Signal Transduction | 2008 |
[Cryoglobulinemia].
Topics: Alcohol Drinking; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C; Humans; Immunologic Factors; Interferon-alpha; Liver Cirrhosis; Male; Recurrence; Ribavirin; Rituximab; Sex Factors; Vasculitis | 2008 |
Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; B-Lymphocytes; Cryoglobulinemia; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab; Vasculitis | 2008 |
Chronic hepatitis C.
Topics: Antiviral Agents; Blood Transfusion; Carcinoma, Hepatocellular; Cryoglobulinemia; Disease Progression; Forecasting; Genotype; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Porphyria Cutanea Tarda; Ribavirin; Risk Factors; Treatment Outcome | 1997 |
Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Cryoglobulinemia; Hepacivirus; Hepatitis C, Chronic; Humans; Immune Complex Diseases; Interferon-alpha; Kidney; Lichen Planus; Microsomes; Microsomes, Liver; Ribavirin; Sialadenitis; Thyroiditis, Autoimmune | 2000 |
Mixed cryoglobulinemia: new concepts.
Topics: Antiviral Agents; Autoimmune Diseases; Cryoglobulinemia; Hepatitis C; Humans; Interferon-alpha; Lupus Erythematosus, Systemic; Ribavirin; Sjogren's Syndrome | 2000 |
[Prevention and treatment of viral hepatitis in renal insufficiency conditions].
Topics: Antiviral Agents; Biopsy; Comorbidity; Contraindications; Cryoglobulinemia; Female; Graft Rejection; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Male; Renal Dialysis; Ribavirin; Severity of Illness Index | 2001 |
Treatment of chronic hepatitis C infection with cryoglobulinemia.
Topics: Antiviral Agents; Cryoglobulinemia; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Interferons; Ribavirin | 2002 |
14 trial(s) available for ribavirin and Cryoglobulinemia
| Article | Year |
|---|---|
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.
Topics: Aged; Antiviral Agents; Cohort Studies; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Ribavirin; Treatment Outcome; Vasculitis | 2014 |
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Proline; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2014 |
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Topics: Antiviral Agents; Cohort Studies; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Time Factors | 2015 |
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome | 2015 |
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Prospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Vasculitis | 2016 |
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
Topics: Aged; Amino Acid Sequence; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; B-Lymphocytes; Base Sequence; Cryoglobulinemia; DNA Primers; Drug Therapy, Combination; Female; Genes, Immunoglobulin Heavy Chain; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver; Longitudinal Studies; Male; Middle Aged; Molecular Sequence Data; Polyethylene Glycols; Prognosis; Prospective Studies; Recombinant Proteins; Remission Induction; Ribavirin; Rituximab; RNA, Viral; Treatment Outcome | 2010 |
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cohort Studies; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Remission Induction; Ribavirin; Rituximab; RNA, Viral; Treatment Outcome | 2010 |
Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.
Topics: Adult; Antiviral Agents; Biopsy; Complementarity Determining Regions; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome | 2003 |
Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
Topics: Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2004 |
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Vasculitis | 2005 |
Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Topics: Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin; Treatment Outcome; Vasculitis | 2006 |
Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab; Treatment Outcome; Vasculitis | 2008 |
Ribavirin in hepatitis C related cryoglobulinemia.
Topics: Aged; Antiviral Agents; Cryoglobulinemia; DNA, Viral; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Recurrence; Ribavirin; RNA, Viral; Transaminases; Treatment Outcome; Viral Load | 1998 |
Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
Topics: Adult; Aged; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin | 2000 |
64 other study(ies) available for ribavirin and Cryoglobulinemia
| Article | Year |
|---|---|
Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report.
Topics: Antiviral Agents; Cryoglobulinemia; Hepatitis C; Humans; Male; Middle Aged; Recurrence; Ribavirin; Sofosbuvir; Sustained Virologic Response | 2017 |
Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Immunologic Factors; Prednisolone; Recurrence; Ribavirin; Rituximab; Sofosbuvir; Viral Load | 2017 |
Lymphoproliferative disease with mixed cryoglobulinemia and hyperviscosity syndrome in an HIV-infected patient: HCV is the only culprit.
Topics: Antiviral Agents; Cryoglobulinemia; Hepacivirus; Hepatitis C; HIV Infections; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Ribavirin | 2017 |
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Pyrrolidines; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |
Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Female; France; Hepatitis E; Humans; Immunocompromised Host; Kidney; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ribavirin; Transplant Recipients | 2018 |
Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Blood Chemical Analysis; China; Cryoglobulinemia; Cryoglobulins; Female; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Hot Temperature; Humans; Interferon alpha-2; Interferon-alpha; Methylprednisolone; Middle Aged; Plasmapheresis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombotic Microangiopathies | 2013 |
[Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment].
Topics: Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis; Hepatitis C; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab; Vasculitis | 2013 |
HCV-associated cryoglobulinaemic vasculitis: triple/dual antiviral treatment and/or rituximab?
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Protease Inhibitors; Ribavirin | 2014 |
HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Protease Inhibitors; Ribavirin | 2014 |
Treatment of chronic hepatitis C complicated by mixed cryoglobulinemia with new protease inhibitor, sofosbuvir.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Protease Inhibitors; Ribavirin | 2014 |
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Topics: Aged; Antiviral Agents; Cryoglobulinemia; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Severity of Illness Index; Treatment Outcome; Vasculitis | 2015 |
Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type I: a case report description.
Topics: Anemia; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Erythropoietin; Glomerulonephritis, Membranoproliferative; Granulocyte Colony-Stimulating Factor; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome | 2014 |
Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.
Topics: Antiviral Agents; Cryoglobulinemia; Glomerulonephritis, Membranoproliferative; Graft Rejection; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nephritis, Hereditary; Ribavirin; Transplant Recipients; Treatment Outcome | 2015 |
A Young Lady with Hypertension - Rare Presentation of a Common Disease.
Topics: Antiviral Agents; Blood Transfusion; Cryoglobulinemia; Female; Glomerulonephritis; Hepacivirus; Hepatitis C; Humans; Hypertension; Interferon-alpha; Kidney Diseases; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2015 |
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Sofosbuvir | 2016 |
Successful treatment of hepatitis C, genotype 3, with sofosbuvir/ledipasvir in decompensated cirrhosis complicated by mixed cryoglobulinaemia.
Topics: Benzimidazoles; Cryoglobulinemia; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate | 2016 |
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Topics: Aged; Antiviral Agents; B-Lymphocytes; Cryoglobulinemia; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Practice Guidelines as Topic; Prospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Vasculitis | 2016 |
HCV-associated cryoglobulinemia vasculitis: are its days numbered?
Topics: Cryoglobulinemia; Hepacivirus; Hepatitis C; Humans; Ribavirin; Sofosbuvir; Vasculitis | 2017 |
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Topics: Aged; Antiviral Agents; B-Lymphocyte Subsets; Biomarkers; Carbamates; Case-Control Studies; Cryoglobulinemia; Cytokines; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis Viruses; Humans; Imidazoles; Immune Tolerance; Immunity, Cellular; Male; Middle Aged; Phenotype; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; T-Lymphocyte Subsets; Time Factors; Treatment Outcome; Valine; Vasculitis; Viral Load | 2017 |
Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Treatment Outcome | 2017 |
Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cell Count; Cryoglobulinemia; Drug Therapy, Combination; Female; Flow Cytometry; Forkhead Transcription Factors; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Remission Induction; Ribavirin; Statistics, Nonparametric; T-Lymphocytes, Regulatory; Treatment Outcome; Vasculitis | 2008 |
Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Cryoglobulinemia; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Prognosis; Recombinant Proteins; Regression Analysis; Retrospective Studies; Ribavirin; Severity of Illness Index; Vasculitis; Viral Load | 2010 |
Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
Topics: Aged; Antiviral Agents; Biopsy; Combined Modality Therapy; Cryoglobulinemia; Drug Therapy, Combination; Edema; Female; Genotype; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney; Plasmapheresis; Polyethylene Glycols; Proteinuria; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2010 |
The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Necrosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2011 |
Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.
Topics: Adrenal Cortex Hormones; Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Biphenyl Compounds; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferative; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Irbesartan; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab; Tetrazoles | 2011 |
[Extrahepatic manifestations in hepatitis C].
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C; Humans; Interferons; Lymphoma, Non-Hodgkin; Remission Induction; Ribavirin; Rituximab | 2012 |
[The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2011 |
Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients.
Topics: Adolescent; Adult; Aged; Cryoglobulinemia; Cryoglobulins; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Young Adult | 2012 |
Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin | 2002 |
Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Remission Induction; Ribavirin | 2002 |
Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Topics: Antiviral Agents; Cryoglobulinemia; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Lymphoma, B-Cell; Ribavirin; RNA, Viral; Splenic Neoplasms | 2002 |
Effect of interferon alfa-2b and ribavirin treatment on hepatitis C-associated cryoglobulinemia and rheumatoid factor: comment on the article by Vassilopoulos and Calabrese.
Topics: Antiviral Agents; Cryoglobulinemia; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Rheumatoid Factor; Ribavirin | 2003 |
Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
Topics: Antihypertensive Agents; Antiviral Agents; Cryoglobulinemia; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Outcome | 2003 |
Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Remission Induction; Ribavirin | 2003 |
Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Drug Resistance, Neoplasm; Drug Resistance, Viral; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Middle Aged; Recombinant Proteins; Remission Induction; Ribavirin; Rituximab; Vasculitis | 2003 |
Cutaneous vasculitis with undetectable cryoglobulinemia in chronic hepatitis C.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin; Skin Diseases; Vasculitis | 2004 |
PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Topics: Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Vasculitis | 2005 |
Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Vasculitis | 2005 |
Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
[Treatment for hepatitis C virus associated cryoglobulinemia with interferon alpha and ribavirin].
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome | 2005 |
Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.
Topics: Antiviral Agents; Cryoglobulinemia; DNA, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Cryoglobulins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Prospective Studies; Ribavirin; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load | 2005 |
Natural history and therapy of 66 patients with mixed cryoglobulinemia.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Databases, Factual; Disease-Free Survival; Female; Follow-Up Studies; Hepatitis C; Humans; Interferons; Kidney Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Peripheral Nervous System Diseases; Purpura; Retrospective Studies; Rheumatic Diseases; Ribavirin; Severity of Illness Index | 2006 |
Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cryoglobulinemia; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon-alpha; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisolone; Remission Induction; Ribavirin; Rituximab | 2006 |
Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.
Topics: Adult; Cryoglobulinemia; Drug Therapy, Combination; Exanthema; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon-alpha; Kidney Transplantation; Male; Ribavirin; Treatment Outcome | 2006 |
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.
Topics: Antiviral Agents; Creatinine; Cryoglobulinemia; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney; Kidney Transplantation; Leg Ulcer; Liver; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
Severe hepatitis C virus-related cryoglobulinaemic sensory-motor polyneuropathy treated with pegylated interferon-a2b and ribavirin: clinical, laboratory and neurophysiological study.
Topics: Adult; Antiviral Agents; Central Nervous System Diseases; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polyneuropathies; Recombinant Proteins; Ribavirin | 2007 |
[A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring during interferon plus ribavirin therapy for chronic hepatitis C].
Topics: Adult; Antiviral Agents; Chronic Disease; Cryoglobulinemia; Facial Paralysis; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Thyroiditis | 2007 |
Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia.
Topics: Antiviral Agents; Corneal Ulcer; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Eye Infections, Viral; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Ribavirin; Scleritis | 2007 |
The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab; Treatment Outcome | 2007 |
Antiviral therapy for cryoglobulinemic neuropathy: comment on the article by Saadoun et al.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Carriers; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin | 2007 |
HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Male; Middle Aged; Ribavirin | 2007 |
Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Topics: Cryoglobulinemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
B-cell depletion in the treatment of mixed cryoglobulinemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; B-Lymphocytes; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lymphocyte Depletion; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab; Treatment Outcome | 2007 |
Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Topics: Adult; Aged; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Vasculitis; Virus Replication | 2008 |
Mixed cryoglobulinemia and membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
Topics: Antiviral Agents; Cryoglobulinemia; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Male; Middle Aged; Ribavirin | 1996 |
Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Female; Follow-Up Studies; Hepatitis C; Humans; Liver Transplantation; Male; Middle Aged; Ribavirin | 1996 |
Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infection.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C; Humans; Middle Aged; Ribavirin; Thrombocytopenia | 1997 |
Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia.
Topics: Adult; Antiviral Agents; Cryoglobulinemia; Drug Evaluation; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin | 1998 |
Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon-alpha; Middle Aged; Ribavirin | 1999 |
Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
Topics: Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver; Logistic Models; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Treatment Outcome | 1999 |
Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Churg-Strauss Syndrome; Cryoglobulinemia; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Ribavirin | 2000 |
Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
Topics: Adult; Aged; Cryoglobulinemia; Diagnosis, Differential; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon-alpha; Male; Nephrotic Syndrome; Ribavirin; Treatment Outcome | 2001 |